DOI: 10.1039/C3OB42196A
Organic & Biomolecular Chemistry
Journal Name
ARTICLE
114.40, 64.29, 55.56, 20.91; HRMS (ESI-TOF) calcd. for (td, J = 7.7, 1.6 Hz, 1H), 7.50–7.48 (m, 1H), 7.33 (t, J = 7.9 Hz,
C16H16N2NaO4 ([M+Na+]) = 323.1008, Found 323.1013.
1H), 7.06 (d, J = 7.6 Hz, 1H), 5.27 (s, 2H), 2.47 (s, 3H), 2.17 (s,
5-Chloro-2-(picolinamido)benzyl acetate (2g): 125 mg, 82%; 3H); 13C NMR (75 MHz, CDCl3) δ 171.31, 162.76, 150.12,
1H NMR (400 MHz, CDCl3) δ 10.58 (s, 1H), 8.61 (d, J = 4.4 148.25, 138.50, 137.58, 137.18, 129.34, 127.18, 126.46, 125.33,
Hz, 1H), 8.27 (dd, J = 12.5, 8.2 Hz, 2H), 7.92 (td, J = 7.7, 1.5 122.59, 121.47, 60.48, 20.88, 19.74; HRMS (ESI-TOF) calcd.
Hz, 1H), 7.54–7.44 (m, 1H), 7.42–7.33 (m, 2H), 5.16 (s, 2H), for C16H16N2NaO3 ([M+Na+]) = 307.1059, Found 307.1065.
2.20 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 170.65, 162.41, 5-Methyl-2-(picolinamido)benzyl acetate (2n): 100 mg, 70%;
149.63, 148.17, 137.76, 135.33, 130.04, 129.63, 129.59, 127.72, 1H NMR (500 MHz, CDCl3) δ 10.50 (s, 1H), 8.61 (d, J = 4.3
126.72, 123.78, 122.62, 63.66, 20.83; HRMS (ESI-TOF) calcd. Hz, 1H), 8.31 (d, J = 7.8 Hz, 1H), 8.14 (d, J = 8.2 Hz, 1H), 7.91
for C15H13ClN2NaO3 ([M+Na+]) = 327.0512, Found: 327.0509.
(td, J = 7.7, 1.5 Hz, 1H), 7.49 (dd, J = 6.7, 4.9 Hz, 1H), 7.26–
2-Fluoro-6-(picolinamido)benzyl acetate (2h): 60 mg, 60%; 7.22 (m, 1H), 7.18 (s, 1H), 5.17 (s, 2H), 2.36 (s, 3H), 2.20 (s,
1H NMR (400 MHz, CDCl3) δ 10.81 (s, 1H), 8.63 (d, J = 4.3 3H); 13C NMR (125 MHz, CDCl3) δ 170.81, 162.32, 150.09,
Hz, 1H), 8.30 (d, J = 7.8 Hz, 1H), 8.12 (d, J = 8.3 Hz, 1H), 7.92 148.10, 137.62, 134.46, 134.23, 130.89, 130.29, 126.43, 126.06,
(t, J = 7.6 Hz, 1H), 7.54–7.44 (m, 1H), 7.40 (dd, J = 15.0, 7.8 122.71, 122.52, 64.53, 20.90, 20.84; HRMS (ESI-TOF) calcd.
Hz, 1H), 6.92 (t, J = 8.8 Hz, 1H), 5.29 (s, 2H), 2.20 (s, 3H); 13C for C16H16N2NaO3 ([M+Na+]) = 307.1059, Found 307.1065.
NMR (100 MHz, CDCl3) δ 171.08, 162.63, 160.10, 149.76, Phenyl(2-(picolinamido)phenyl)methyl acetate (2o): 120 mg,
1
148.23, 138.59, 137.70, 130.66, 126.69, 122.66, 118.28, 113.98, 69%; H NMR (400 MHz, CDCl3) δ 10.59 (s, 1H),8.61–8.60
111.43, 56.72, 20.80; HRMS (ESI-TOF) calcd. for (m, 1H), 8.28 (dd, J = 13.2, 8.0 Hz, 2H), 7.87 (td, J = 7.7, 1.7
C15H13FN2NaO3 ([M+Na+]) = 311.0808, Found 311.0810.
Hz, 1H), 7.50–7.43 (m, 1H), 7.43–7.35 (m, 4H), 7.33–7.23 (m,
2-Chloro-6-(picolinamido)benzyl acetate (2i): 102 mg, 67%; 3H), 7.23–7.15 (m, 1H), 7.08 (s, 1H), 2.26 (s, 3H); 13C NMR
1H NMR (400 MHz, CDCl3) δ 10.87 (s, 1H), 8.65 (s, 1H), 8.31 (100 MHz, CDCl3) δ 169.97, 162.35, 149.90, 147.96, 138.44,
(d, J = 7.1 Hz, 1H), 8.18 (d, J = 7.9 Hz, 1H), 7.93 (s, 1H), 7.52 137.58, 135.71, 130.40, 129.21, 128.94, 128.47, 128.04, 126.87,
(s, 1H), 7.36 (d, J = 7.9 Hz, 1H), 7.26 (d, J = 7.6 Hz, 1H), 5.40 126.46, 124.85, 123.38, 122.48, 74.93, 21.19; HRMS (ESI-TOF)
(s, 2H), 2.22 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.17, calcd. for C21H18N2NaO3 ([M+Na+]) = 369.1215, Found
162.69, 149.75, 148.26, 138.74, 137.70, 135.46, 130.35, 126.70, 369.1220.
125.91, 124.36, 122.69, 121.78, 60.70, 20.81; HRMS (ESI-TOF) 1-(2-(Picolinamido)phenyl)ethyl acetate (2p): 64 mg, 45%;
calcd. for C15H13ClN2NaO3 ([M+Na+]) =327.0512, Found 1H NMR (400 MHz, CDCl3) δ 10.86 (s, 1H), 8.65 (d, J = 4.1
327.0518.
Hz, 1H), 8.32 (d, J = 7.8 Hz, 1H), 8.24 (d, J = 7.9 Hz, 1H), 7.92
1
2-(Picolinamido)benzyl acetate (2j): 115 mg, 85%; H NMR (td, J = 7.7, 1.7 Hz, 1H), 7.49 (m, 1H), 7.39 (dd, J = 12.1, 4.5
(500 MHz, CDCl3) δ 10.62 (s, 1H), 8.64 (d, J = 4.1 Hz, 1H), Hz, 2H), 7.24–7.12 (m, 1H), 6.03 (q, J = 6.7 Hz, 1H), 2.17 (s,
8.33 (d, J = 7.9 Hz, 2H), 7.94 (m, 1H), 7.51 (m, 1H), 7.46 (m, 3H), 1.62 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
1H), 7.40 (d, J = 6.9 Hz, 1H), 7.20 (t, J = 7.5 Hz, 1H), 5.23 (s, 170.42, 162.57, 150.17, 148.21, 137.61, 135.41, 131.54, 128.97,
2H), 2.23 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.66, 127.52, 126.44, 125.02, 123.51, 122.59, 70.97, 21.25, 20.50;
162.34, 150.08, 148.09, 137.62, 136.91, 130.28, 129.74, 126.46, HRMS (ESI-TOF) calcd. for C16H16N2NaO3 ([M+Na+]) =
126.02, 124.62, 122.55(2C), 64.49, 20.82; HRMS (ESI-TOF) 307.1059, Found 307.1065.
calcd. for C15H14N2NaO3 ([M+Na+]) = 293.0902, Found (3,3-Dimethylindolin-1-yl)(pyridin-2-yl)methanone (2q): 67
1
293.0910.
mg, 53%; H NMR (300 MHz, CDCl3) δ 8.64 (d, J = 4.4 Hz,
5-Bromo-4-fluoro-2-(picolinamido)benzyl acetate (2k): 140 1H), 8.29 (d, J = 8.0 Hz, 1H), 7.87 (m, 2H), 7.53–7.33 (m, 1H),
mg, 76%; 1H NMR (500MHz, CDCl3) δ 10.71 (s, 1H), 8.62 (d, 7.33–7.23 (m, 1H), 7.22–7.06 (m, 2H), 4.09 (s, 2H), 1.33 (s,
J = 3.8 Hz, 1H), 8.34 (d, J = 10.7, 1H), 8.30 (d, J = 7.6 Hz, 1H), 6H); 13C NMR (75 MHz, CDCl3) δ 166.08, 154.57, 148.15,
7.94 (t, J = 7.4 Hz, 1H), 7.53 (m, 2H), 5.15 (s, 2H), 2.20 (s, 3H); 142.05, 141.54, 137.21, 127.71, 125.17, 124.80, 124.42, 121.99,
13C NMR (100 MHz, CDCl3) δ 170.60, 162.36, 160.63, 158.17, 118.04, 65.15, 40.73, 30.42, 28.30; HRMS (ESI-TOF) calcd.
149.35, 148.20, 137.86, 137.67, 134.61, 126.92, 122.70, 110.23, for C16H16N2NaO ([M+Na+]) = 275.1160, Found 275.1165.
103.19, 63.11, 20.82; HRMS (ESI-TOF) calcd. for (2-(Picolinamido)cyclohexyl)methyl acetate (2r): 86 mg, 62%;
C15H12BrFN2NaO3 ([M+Na+]) = 388.9913, Found 388.9920.
1H NMR (500 MHz, CDCl3) δ 8.60–8.49 (m, 1H), 8.19 (d, J =
4-Bromo-5-chloro-2-(picolinamido)benzyl acetate (2l): 129 7.8 Hz, 1H), 8.01 (d, J = 8.6 Hz, 1H), 7.85 (td, J = 7.7, 1.7 Hz,
mg, 67%; 1H NMR (400 MHz, CDCl3) δ10.66 (s, 1H), 8.63 (d, 1H), 7.42 (m, 1H), 4.11 (m, 1H), 4.00 (dd, J = 11.2, 6.2 Hz,
J = 4.4 Hz, 1H), 8.59 (s, 1H), 8.30 (d, J = 7.7 Hz, 1H), 7.95 (m, 1H), 3.90 (m, 1H), 2.17–2.06 (m, 1H), 1.98 (s, 3H), 1.95–1.85
1H), 7.62 (s, 1H), 7.54 (m, 1H), 5.16 (s, 2H), 2.22 (s, 3H);13C (m, 1H), 1.77 (m, 3H), 1.41 (m, 1H), 1.35–1.24 (m, 3H); 13C
NMR (100 MHz, CDCl3) δ 170.54, 162.34, 149.32, 148.21, NMR (75 MHz, CDCl3) δ 171.18, 163.64, 149.86, 147.93,
137.85, 136.87, 135.54, 134.68, 126.91, 125.72, 123.55, 122.68, 137.40, 126.14, 122.34, 66.89, 50.21, 42.54, 33.44, 29.00,
116.94, 63.02, 20.80; HRMS (ESI-TOF) calcd. for 25.15, 25.09, 20.89; HRMS (ESI-TOF) calcd for
C15H12BrClN2NaO3 ([M+Na+]) = 404.9618, Found 404.9623.
C15H20N2NaO3 ([M+Na+]) = 299.1372, Found 299.1380.
2-Methyl-6-(picolinamido)benzyl acetate (2m): 100 mg, 70%; (3-Methylazetidin-1-yl)(pyridin-2-yl)methanone (2s): 70 mg,
1
1H NMR (500 MHz, CDCl3) δ 10.72 (s, 1H), 8.65 (d, J = 4.6 80%; H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 4.2 Hz, 1H),
Hz, 1H), 8.31 (d, J = 7.8 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.92 8.08 (d, J = 7.8 Hz, 1H), 7.78 (dd, J = 10.9, 4.5 Hz, 1H), 7.34
This journal is © The Royal Society of Chemistry 2012
J. Name., 2012, 00, 1-3 | 5